Directly following the cell therapy panel discussion in part 1, Precision experts Deb Phippard and David Parker, and Project Pharma’s Tony Khoury will join C-Suite leaders from advanced therapy companies for “Considerations for the Clinical Development of Cell & Gene Therapies.” Part 2- Gene Therapy- Tuesday, May 11, 2021, 6:00-6:45PM ET.

For more information about ASGCT, click here.